Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 3
2014 12
2015 12
2016 16
2017 24
2018 34
2019 37
2020 35
2021 42
2022 47
2023 38
2024 37
2025 23

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Results by year

Filters applied: . Clear all
Page 1
Extending Current Guideline-recommended Prostate-specific Antigen Density Thresholds for Improving Benefit/Harm Balance in Risk-based Magnetic Resonance Imaging-directed Prostate Cancer Diagnosis, from the Community-based Multicentre MR-PROPER Study.
Prinsen AMA, Wagensveld IM, Osses DF, Groenendijk PM, Zijta FM, Busstra MB, Rociu E, Barentsz JO, Sedelaar JPM, Arbeel B, Roeleveld T, Geenen R, Koeter I, van der Meer S, Cappendijk VC, Klaver S, van der Lely H, Wolters T, Leter MR, van der Poel HG, Heijmink SWTPJ, Immerzeel J, Leijte JAP, van Roermund JGH, Miclea RL, Planken E, Vis AN, de Jong IJ, Tijsterman J, Wolterbeek D, Claessen A, Nederend J, Bangma CH, Roobol MJ, Remmers S, van den Bergh RCN, Somford DM, Schoots IG. Prinsen AMA, et al. Eur Urol Oncol. 2025 Nov 28:S2588-9311(25)00290-1. doi: 10.1016/j.euo.2025.11.002. Online ahead of print. Eur Urol Oncol. 2025. PMID: 41318235 Free article.
Study protocol for the DISTINCT trial: inDividual, targeted thrombosIS prophylaxis versus the standard 'one-size-fits-all' approach in patients undergoing Total hIp or total kNee replaCemenT - a national, multicentre, randomised, multiarm, open-label trial.
Kok RY, van Bodegom-Vos L, Ettema HB, Groenwold RHH, van den Hout WB, Huisman MV, Klok FA, Nelissen RGHH, van Rein N, van Veen M, Vehmeijer SBW, Wiegerinck JJI, Cannegieter SC, Nemeth B. Kok RY, et al. BMJ Open. 2025 Oct 6;15(10):e101180. doi: 10.1136/bmjopen-2025-101180. BMJ Open. 2025. PMID: 41057196 Free PMC article.
Sex Differences in Patient-Rated Outcomes After Lumbar Spinal Fusion for Degenerative Disease: A Multicenter Cohort Study.
Ciobanu-Caraus O, Grob A, Rohr J, Stumpo V, Ricciardi L, Maldaner N, Eversdijk HAJ, Vieli M, Raco A, Miscusi M, Perna A, Proietti L, Lofrese G, Dughiero M, Cultrera F, D'Andrea M, An SB, Ha Y, Amelot A, Cadelo JB, Viñuela-Prieto JM, Gandía-González ML, Girod PP, Lener S, Kögl N, Abramovic A, Laux CJ, Farshad M, O'Riordan D, Loibl M, Galbusera F, Mannion AF, Scerrati A, De Bonis P, Molliqaj G, Tessitore E, Schröder ML, Stienen MN, Brandi G, Regli L, Serra C, Staartjes VE. Ciobanu-Caraus O, et al. Spine (Phila Pa 1976). 2025 Jul 1;50(13):924-931. doi: 10.1097/BRS.0000000000005183. Epub 2024 Oct 17. Spine (Phila Pa 1976). 2025. PMID: 39453385 Free PMC article.
289 results